Chalothorn “Sai” Wannaphut, MD
@Sai_Wannaphut
MD 🇹🇭 | PGY-3 @ Univ of Hawai‘i JABSOM 🇺🇸 | Hem/Onc Fellowship Applicant | ASCO/ASH Member | AAMC ID: 14490577 #Match2026 #WomenInMedicine
🚀 Officially submitted my ERAS application for the 2026 Hematology/Oncology Fellowship Match! Grateful for the mentors, patients, and friends who’ve shaped this journey. Looking forward to the next chapter in cancer care, equity, and innovation. 🙏🏽✨ 📋 AAMC ID: 14490577…

🤩Honored to contribute to this important study! Grateful for the guidance of my mentor, Dr.Arya🙏 @royaryam in shaping this work. 💫 🔗ascopubs.org/doi/10.1200/JC… #ASCO25 #BreastCancer #Incidence #Survival #MedTwitter #Oncology @oncodaily @IMG_Oncologists @HemOncFellows…
Proud to present our work at the 2025 @ASCO Annual Meeting, now in JCO! Incidence and survival outcomes of breast cancer subtypes in the United States • Studied US breast cancer (BC) subtypes (2000–2021) 🩺 • Incidence: Ductal (79.1%), lobular (10.9%), mucinous (2.8%),…
Honored to receive a 2025 Conquer Cancer Merit Award - @Sai_Wannaphut @ASCO @ConquerCancerFd oncodaily.com/url/336811 #OncoDaily #Oncology #Cancer #Health #Medicine #MedX
🏅 Honored to receive a 2025 Conquer Cancer Merit Award from @ConquerCancerFd @ASCO for our abstract on lung cancer disparities—selected for poster presentation at #ASCOQLTY25! 📌 Survival Disparities in NSCLC: Disaggregating Asians from NHPI in Hawaiʻi 🙏 Thank you to the…


Good luck Sai @Sai_Wannaphut ! Kindness teeming, horizon of your vitality is par-less. Rooting for you to match in your first choice.
🚀 Officially submitted my ERAS application for the 2026 Hematology/Oncology Fellowship Match! Grateful for the mentors, patients, and friends who’ve shaped this journey. Looking forward to the next chapter in cancer care, equity, and innovation. 🙏🏽✨ 📋 AAMC ID: 14490577…
Sai was my upper on few rotations during my intern year. She's always available for help and never turns anyone down. A great teacher and senior. Any program would be lucky to have you, truly dedicated to the field!
🚀 Officially submitted my ERAS application for the 2026 Hematology/Oncology Fellowship Match! Grateful for the mentors, patients, and friends who’ve shaped this journey. Looking forward to the next chapter in cancer care, equity, and innovation. 🙏🏽✨ 📋 AAMC ID: 14490577…
Wish you all the best!! 🫶🏽🤩
🚀 Officially submitted my ERAS application for the 2026 Hematology/Oncology Fellowship Match! Grateful for the mentors, patients, and friends who’ve shaped this journey. Looking forward to the next chapter in cancer care, equity, and innovation. 🙏🏽✨ 📋 AAMC ID: 14490577…
🙋♀️Hello!! How's your schedule this fall? 🌟#WomenInOncology, save Sep 27-28 for #LEAD25! It's a fantastic opportunity for career development, networking with many inspiring and impactful women in oncology! 👉 bioascend.com/lead/ @JulieBrahmer @AnaVManana @KatieLaiMD_MPH…
✍️Mark your calendar for our next upcoming space❗️ Mastering the Eras Application - What to Focus On: Signaling and Experiences? ‼️ Speaker: @THilalMD, Heme/Onc Fellowship PD at Mayo Clinic, Arizona Host: @DrSAHaddad ⏰Wednesday, July 9th, 2025 📍X space, 7 pm EST
@HemOncFellows @drtulsijose @Noha_Soror @YLeyfman @AviHarisingani @Sai_Wannaphut @rafikelbebmd
🚨 Knowledge, Attitude, and Barriers to Sexual health Counseling for Patients with Breast Cancer - A global study of oncology fellows. Help us improve care by sharing your experience 🩺 forms.gle/XHGLfdTJFeVT7e… @hemeoncfellow
Honored to Be The Top Winner in the Why I Research Challenge - Chalothorn Wannaphut @SciProfiles @Sai_Wannaphut @royaryam @ASCO oncodaily.com/blog/chalothor… #Cancer #HealthEquity #BreastCancer #AYAonc #MedX #MedNews #MedEd #OpenScience #Medicine #Health #Oncology #OncoDaily
Don’t miss our special session tomorrow with @ConquerCancerFd! We’ll explore opportunities for trainees and early-career oncologists, share tips on how to make your application stand out, and cover everything you need to know about applying. @IMG_Oncologists @ASCOTECAG
Register here for our upcoming space on the 1st of July❗️ docs.google.com/forms/d/e/1FAI…
🚨Proud to share our publication in @JCOOP_ASCO 🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! @DrChoueiri @NazliDizman @ZiadBakouny @IMG_Oncologists @GlopesMd
Breaking: Big news for smoldering myeloma. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of a new indication for DARZALEX®(daratumumab) subcutaneous (SC) formulation as monotherapy for the treatment…
✍️Mark your calendar for our next upcoming space‼️ Conquer Conversations; Navigating Career Development with Conquer Cancer Support🏆 Speaker: Julia Schwartz/@ConquerCancerFd Host: @Noha_Soror ⏰Tuesday, 1st July, 2025 📍Zoom, 17:30 pm EST (Scan QR code for registration)
Incidence and Survival Outcomes of Breast Cancer Subtypes in the United States @SakditadMD @Sai_Wannaphut @ASCO oncodaily.com/url/307680 #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer #CancerWorld #BreastCancer #ASCO25
✨Honored to be a co-author on this important work presented at #ASCO25 @ASCO Proud to support IMG visibility in HemOnc. 🙌 Thank you 🙏 @royaryam and our amazing team for leading the way! 📌 IMG fellows had 5.7 more manuscripts than AMGs on average (p < 0.001), despite having…
Excited to present our research today at #ASCO25 @ASCO! IMG exhibit higher research productivity compared to AMGs - matrix that helps PDs to recruit more IMGs to hemonc fellowship programs! @IMG_Oncologists @NazliDizman @ArdeshirFatemeh @ZiadBakouny @DrChoueiri @OhioStateMedOnc